|
Field
Last Published
|
Before
November 11, 2020 02:30 PM
|
After
December 16, 2020 09:49 AM
|
|
Field
Planned Number of Clusters
|
Before
Phase 1: 12,000 individuals (not clustered)
Phase 2: 200 pharmacies
|
After
Phase 1: 10,000 individuals (not clustered)
Phase 2: 200 pharmacies
|
|
Field
Planned Number of Observations
|
Before
Phase 1: 12,000 individuals
Phase 2: 12,000 individuals
|
After
Phase 1: 10,000 individuals
Phase 2: 12,000 individuals
|
|
Field
Sample size (or number of clusters) by treatment arms
|
Before
Phase 1: 2400 individuals control (no subsidy offer), 2400 individuals high RDT + high ACT subsidy offer, 2400 individuals high RDT + low ACT subsidy offer, 2400 individuals low RDT + high ACT subsidy offer, 2400 individuals low RDT + low ACT subsidy offer.
Phase 2: 50 sites control, 50 sites patient subsidy, 50 sites performance incentive, 50 sites hybrid patient subsidy & performance incentive
|
After
Phase 1: 2000 individuals control (no subsidy offer), 2000 individuals high RDT + high ACT subsidy offer, 2000 individuals high RDT + low ACT subsidy offer, 2000 individuals low RDT + high ACT subsidy offer, 2000 individuals low RDT + low ACT subsidy offer.
Phase 2: 50 sites control, 50 sites patient subsidy, 50 sites performance incentive, 50 sites hybrid patient subsidy & performance incentive
|